Megace ES Related Published Studies
Well-designed clinical trials related to Megace ES (Megestrol)
[Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss]. [2011.07.23]
Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17beta-estradiol (NOMAC/E2): a double-blind, randomized study. [2011.06]
Antiemetic activity of megestrol acetate in patients receiving chemotherapy. [2011.05]
Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17beta-oestradiol: a double-blind, randomised, dose-finding pilot study. [2011.04]
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17beta-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study. [2011.03]
The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women. [2010.12]
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. [2010.10]
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care. [2010.04.13]
Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia. [2010.01]
Report of a Pilot, Double-Blind, Placebo-Controlled Study of Megestrol Acetate in Elderly Dialysis Patients With Cachexia. [2009.10.09]
Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. [2009.05]
Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. [2009.03]
Is megestrol acetate a suitable option for treatment of hot flashes in women with breast cancer? [2008.12]
Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis. [2008.11]
Is megestrol acetate a suitable option for treatment of hot flashes in women with breast cancer? [2008.09.30]
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. [2008.04.01]
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up. [2008.01]
Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). [2008]
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. [2007.02]
Effects of muscle strength training and megestrol acetate on strength, muscle mass, and function in frail older people. [2007.01]
Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. [2006]
Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. [2005.07]
Nomegestrol acetate may enhance the skeletal effects of estradiol on biochemical markers of bone turnover in menopausal women after a 12-week treatment period. [2005.06]
The effects of megestrol acetate suspension for elderly patients with reduced appetite after hospitalization: a phase II randomized clinical trial. [2005.06]
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. [2004.06.15]
Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months. [2004.03.15]
Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids. [2004]
Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis. [2003.12]
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate. [2003.07]
Megestrol acetate-induced weight gain does not negatively affect blood lipids in elderly men: effects of resistance training and testosterone replacement. [2003.07]
[Comparison of changes in biochemical markers of bone turnover after 6 months of hormone replacement therapy with either transdermal 17 beta-estradiol or equine conjugated estrogen plus nomegestrol acetate] [2003.05]
Effects of testosterone replacement and/or resistance training on interleukin-6, tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. [2003.02]
Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. [2003]
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma. [2002.12]
Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses. [2002.07]
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. [2002.06]
Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. [2002.05]
Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy. [2002.04.01]
Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. [2002.04]
Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. [2002.04]
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. [2002.01.15]
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. [2002.01]
[Clinical study on treatment of female idiopathic precocious puberty with combined therapy of Chinese medicine and megestrol acetate] [2001.10]
A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. [2001.08]
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. [2001.07.15]
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. [2001.04.06]
Well-designed clinical trials possibly related to Megace ES (Megestrol)
Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. [2010.06]
Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia. [2010.04]
Thrombotic risk and immobility in residents of long-term care facilities. [2010.03]
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy. [2010.02]
Progestin-only pills for contraception. [2010.01.20]
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. [2010]
Elevated plasma endoglin (CD105) predicts decreased response and survival in a
metastatic breast cancer trial of hormone therapy. [2010]
Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. [2009.07.07]
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial. [2008.05.10]
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. [2008.04]
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer. [2007.05.15]
Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women. [2007.05]
A model for cystic endometrial hyperplasia/pyometra complex in the bitch. [2006.10]
The influence of exogenous progestin on the occurrence of proestrous or estrous signs, plasma concentrations of luteinizing hormone and estradiol in deslorelin (GnRH agonist) treated anestrous bitches. [2006.10]
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre. [2006.03]
Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. [2006.02.20]
Bleeding patterns during continuous estradiol with different sequential progestogens therapy. [2005.09]
Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. [2004.10]
Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. [2004.09]
A comparison of the central effects of different progestins used in hormone replacement therapy. [2004.08.20]
Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. [2004.07]
Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy. [2003.07.25]
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy. [2003.05]
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer. [2002.08]
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. [2002.03.15]
Effects of a short-term suspension of hormone replacement therapy on mammographic density. [2001.09]
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study. [2000.09]
Other research related to Megace ES (Megestrol)
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial
cancer: a gynecologic oncology group study. [2014]
Conservative therapy with metformin plus megestrol acetate for endometrial
atypical hyperplasia. [2014]
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. [2011.10.31]
Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma. [2011.09.27]
Nomegestrol acetate, a novel progestogen for oral contraception. [2011.05]
Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability. [2011.01]
[Analysis of the initial efficacy of nedaplatin combined with megestrol in
concurrent chemoradiotherapy for advanced cervical cancer]. [Article in Chinese] [2011]
Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive
advanced hepatocellular carcinoma. [2011]
Antiemetic activity of megestrol acetate in patients receiving chemotherapy. [2011]
Megestrol acetate improves weight gain in pediatric patients with chronic kidney disease. [2010.11]
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. [2010.08]
Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate. [2010.06]
Antiemetic activity of megestrol acetate in patients receiving chemotherapy. [2010.04.26]
Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy. [2010.03.26]
Megestrol and embryonic extracts in the treatment of advanced hepatocellular carcinoma: A prospective randomized trial in the pre-sorafenib era. [2010.02]
Megestrol acetate therapy for advanced low-grade endometrial stromal sarcoma. [2010]
[Treatment of uraemic anorexia with megestrol acetate]. [2010]
The use of nomegestrol acetate in rapid preparation of endometrium before
operative hysteroscopy in pre-menopausal women. [2010]
Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in
elderly dialysis patients with cachexia. [2010]
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a
randomized trial. [2010]
[Nomegestrol acetate: clinical pharmacology] [2009.10]
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. [2009.09.11]
An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability. [2009.04]
Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly. [2009.04]
Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients. [2009.02]
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension. [2009]
Influence of megestrol acetate on nutrition and inflammation in dialysis patients - preliminary results. [2009]
The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. [2008.11]
|
